Color Doppler Ultrasonography Evaluation of Abdominal and Peripheral Vasculopathy in Systemic Sclerosis Patients

Last updated: June 1, 2025
Sponsor: Assiut University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Scleroderma

Connective Tissue Diseases

Scar Tissue

Treatment

Colour Doppler Ultrasound

Clinical Study ID

NCT07012655
SFA12025
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

In the current study we aim to assess the macrovascular involvement in SSc patients through an ultrasound (US) evaluation of radial and ulnar arteries and splanchnic vessels.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adult systemic sclerosis patients fulfilling the criteria for the diagnosis byAmerican College of Rheumatology /European league against rheumatism 2013classification criteria for systemic sclerosis, who accept to participate in thecurrent study.

Exclusion

Exclusion Criteria:

  • Individuals with other autoimmune diseases (rheumatoid arthritis, dermatomyositis,mixed connective tissue disease).

  • those who Refuse to participate in the current study.

Study Design

Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Colour Doppler Ultrasound
Phase:
Study Start date:
May 01, 2024
Estimated Completion Date:
September 01, 2025

Study Description

Systemic sclerosis (SSc) is a connective tissue disease (CTD) characterized by diffuse cutaneous sclerosis of skin and organs, small vessel vasculopathy and immune system dysregulation associated with the production of autoantibodies.

Although small vessel vasculopathy can be considered a hallmark of this disease, large vessels can also be involved. Accordingly, involvement of medium vessels such as the ulnar artery has been evaluated in the literature, with results showing how ulnar artery occlusion (UAO) could be considered as a severity marker of vasculopathy as well as a predictive marker of digital ulcers (DUs), which are typically more frequent in patients with limited cutaneous (lc) SSc.

The gastrointestinal (GI) tract is one of the most frequently involved organs, affecting the majority (75-90%) of SSc patients.

GI involvement is often largely asymptomatic because it is frequently subclinical until severe tissue damage occurs. Once symptoms occur, SSc-related GI involvement heavily impacts morbidity and mortality, with patients experiencing significant emotional and social burdens and decreased survival in severe cases.

Unfortunately, the diagnosis of GI involvement is challenging because it is often delayed by the paucity of signs and symptoms early in the disease. Moreover, several diagnostic investigations that are useful in defning GI involvement are either invasive, expensive or not very informative.

Understanding the etiology and early phases of GI involvement, therefore, remains a high priority in SSc research. The aim would be to identify patients at high risk of developing progressive GI involvement, monitor disease activity, in the vessels or other relevant tissues, and intervene before the development of signifcant damage/dysfunction.

Bandini et al. showed how potentially the splanchnic vessels in SSc may be non-invasively investigated with abdominal US and color Doppler US, showing that some morphological and functional US parameters of mesenteric arteries of SSc patients are different from healthy controls defining a "bowel vasculopathy".

Abdominal ultrasound (US) is a unique tool that allows for the noninvasive assessment of the vasculature and major parts of the GI tract, including extra-intestinal features and splanchnic vessels as well as peripheral vessels.

Connect with a study center

  • Assiut University hospital

    Assiut, 71515
    Egypt

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.